AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU

(RTTNews) - AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy for limited-stage small cell lung cancer. The CHMP of the European Medicines Agency based its positive opinion on the results from the https://www.nasdaq.com/articles/astrazeneca-chmp-recommends-approval-imfinzi-eu